You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Medtronic
Mallinckrodt
Johnson and Johnson
Dow

Last Updated: January 24, 2021

DrugPatentWatch Database Preview

Litigation Details for Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd. (N.D. Cal. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd. (N.D. Cal. 2013)

Docket   Start Trial Date Filed 2013-04-26
Court District Court, N.D. California Date Terminated 2014-09-05
Cause 35:145 Patent Infringement Assigned To Lucy Haeran Koh
Jury Demand None Referred To Paul Singh Grewal
Parties PAR PHARMACEUTICAL, INC.
Patents 6,228,398; 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755; 8,105,626; 8,173,158; 8,461,187
Attorneys Deepro R. Mukerjee
Firms Crowell & Moring, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd. (N.D. Cal. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-04-26 1 Paragraph lV Certifications from Handa for U.S. Patent Nos. 6,462,058; 6,664,276; 6,939,971; 7,285,668; and 7,…non-infringement of U.J. Patent Nos. 8,105,626 (“the ’626 Patent”) and 8,173,158 (“the ’158 Patent”) pursuant to …the ’158 Patent and/or the ’626 Patent, or that one or more of the Defendants will file a patent infringement…TPC is the named assignee of the ’626 Patent, 17. The ’158 Patent, entitled “Methods of Treating Gastrointestinal…Administration (“FDA”) to list the ’158 Patent and the ’626 Patent in FDA’s Approved Drug Products with External link to document
2013-07-09 29 and U.S. Patent No. 7,790,755 10 (the “’755 Patent), which…captioned matter concerns infringement of United States Patent No. 8,173,158 … (“the ’158 Patent”). On June 25, 2013, Takeda Pharmaceutical Company…each of which concerns infringement of the ’158 patent (“’158 Actions”): …which Impax alleges is similar to the ’158 Patent. See id. In those cases, (the For the Northern District External link to document
2013-10-28 56 Mylan infringed on five other patents associated with Dexilant: 6,462,058; 6,664,276; 6,939,971; … 17 patents 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755… 8 concerns the patents at issue in the ‘755 Actions and not the patents at issue in the ‘158 Actions…America, Inc. (collectively, “Takeda”) related to patents 22 …alleges that Mylan infringed on two of the Takada patents associated with Dexilant: External link to document
2014-06-06 78 Order CONSTRUING DISPUTED CLAIM TERMS OF U.S. PATENT NOS. 8,461,187 AND 8,173,158. Signed by Judge Lucy Koh on 6/6/… 5 September 2014 5:13-cv-01927 830 Patent None District Court, N.D. California External link to document
2014-06-06 95 incorporation by reference of two separate patents, Nos. 5,017,381 and 6,228,398. See id. col.7 …simultaneously”); U.S. Patent 9 No. 6,228,398 col.4 ll.56-59 (… terms in the claims of the two asserted patents: U.S. Patent Nos. 8,461,187 (the … “’187 Patent”) and 8,173,158 (the “’158 Patent”). The Court held a technology…with two types of solid particles. ’158 Patent cl.1. The ’158 Patent notes the preexisting problem External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Moodys
Merck
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.